A new case study published in Cureus by Saami Khalifian, MD; Alec D. McCarthy, MD; and Steven Yoelin, MD, examines the efficacy and safety of an injectable therapy for treating neck wrinkles and skin laxity. This therapy combines hyperdiluted calcium hydroxylapatite (CaHA), platelet-rich plasma (PRP), and hyaluronidase.
Two patients with moderate neck wrinkles and skin laxity received the treatment and were evaluated several months later.
The study found that a single treatment with the combined therapy improved skin texture and laxity.
The inclusion of PRP and hyaluronidase aimed to enhance the regenerative effects of CaHA. PRP is rich in growth factors that stimulate collagen production and regeneration, while hyaluronidase breaks down hyaluronic acid, promoting better diffusion and even product dispersion.
The findings from these cases provide preliminary evidence supporting the safety and efficacy of this innovative combination therapy for addressing neck wrinkles and laxity.
According to the researchers, this is the first documented instance of using CaHA in conjunction with hyaluronidase and PRP for skin priming.
Further investigations are needed to explore the application of this treatment for other anatomical regions and to clarify the role of each injected component.
Read complete findings at Cureus
More from The Blog
Going Beyond the Graphic: Boosting Your Marketing and SEO Impact
MedSpas thrive on visuals—from stunning before-and-after photos to eye-catching promotions for specials like Valentine’s Day and monthly offers. While these graphics are the shiny, attractive exterior of your marketing efforts, they need the “engine” of compelling...
New Treatment for Frown Lines Unveiled at IMCAS: RelabotulinumtoxinA by Galderma
In the ever-evolving world of aesthetic medicine, staying ahead on top of new developments and treatments is crucial for medspa owners. The recent International Master Course on Aging Science (IMCAS) conference, which concluded last week, brought together leading...
Hyperpersonalization Isn’t Optional Anymore—It’s the Key to Thriving in 2025
The Problem with AI-Generated Content: A Sea of Sameness Let’s face it—AI has revolutionized content creation. With just a few clicks, anyone can generate blog posts, social media captions, and even email campaigns... and just like that everything looks/feels/reads...
Breaking News: Evolus Prepares for Evolysse™ Launch with FDA Approval
Evolus, the aesthetics company known for Jeuveau®, has announced record-breaking financial results for 2024 and is preparing to disrupt the dermal filler market with the highly anticipated launch of Evolysse™. While the official launch is expected in Q2 2025 now that...
